You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/7832
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChin, Chung Man-
dc.contributor.authorBosquesi, Priscila Longhin-
dc.contributor.authordos Santos, Jean Leandro-
dc.date.accessioned2014-05-20T13:24:52Z-
dc.date.accessioned2016-10-25T16:45:32Z-
dc.date.available2014-05-20T13:24:52Z-
dc.date.available2016-10-25T16:45:32Z-
dc.date.issued2011-11-01-
dc.identifierhttp://dx.doi.org/10.2174/138161211798194512-
dc.identifier.citationCurrent Pharmaceutical Design. Sharjah: Bentham Science Publ Ltd, v. 17, n. 32, p. 3515-3526, 2011.-
dc.identifier.issn1381-6128-
dc.identifier.urihttp://hdl.handle.net/11449/7832-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/7832-
dc.description.abstractIn therapeutics research, the nitro compounds are part of an important group of drugs with multiple pharmacological activities. However, in drug design, the inclusion of a nitro group in a molecule changes the physico-chemical and electronic properties and is associated with increased mutagenicity and carcinogenicity. In addition, several studies have related the relationship between the antimicrobial and/or anti-protozoal activity and the mutagenic effect to reduction of the nitro group. This work reviews the toxicity of nitro compounds and shows how the use of prodrugs can increase the biological activity and decrease the genotoxicity of nitro compounds, without any modification in nitro reduction behavior, but rather by physico-chemical improvement. Examples are given of metronidazole and nitrofurazone prodrugs.en
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)-
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)-
dc.description.sponsorshipPrograma de Apoio ao Desenvolvimento Científico da Faculdade de Ciências Farmacêuticas da UNESP (PADC)-
dc.format.extent3515-3526-
dc.language.isoeng-
dc.publisherBentham Science Publ Ltd-
dc.sourceWeb of Science-
dc.subjectProdrugsen
dc.subjectnitro-compoundsen
dc.subjectmetronidazolen
dc.subjectnitrofurazoneen
dc.subjectgenotoxicityen
dc.subjectphysico-chemical propertiesen
dc.titleA Prodrug Approach to Improve the Physico-Chemical Properties and Decrease the Genotoxicity of Nitro Compoundsen
dc.typeoutro-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.description.affiliationUniv São Paulo State UNESP, Sch Pharmaceut Sci, Lapdesf Lab Drug Desing, Dept Drugs & Med, BR-14802901 Araraquara, SP, Brazil-
dc.description.affiliationUnespUniv São Paulo State UNESP, Sch Pharmaceut Sci, Lapdesf Lab Drug Desing, Dept Drugs & Med, BR-14802901 Araraquara, SP, Brazil-
dc.identifier.doi10.2174/138161211798194512-
dc.identifier.wosWOS:000299637000005-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofCurrent Pharmaceutical Design-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
Show simple item record Show full item record   View Statistics
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.